Trademarkia Logo

Canada

C$
Trademark Search in Canada
SOTIO

View On IC.GC.CA

SOTIO
REGISTERED

on 5 Oct 2020

Last Applicant/ Owned by

SOTIO BIOTECH A.S.

ID no. 109 00 004Jankovcova 1518/2170 00 Prague 7,

CZ

Serial Number

1851998 filed on 10th Aug 2017

Registration Number

TMA1083410 registered on 5th Oct 2020

Registration expiry Date

5th Oct 2030

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

SOTIO

Trademark usage description

pharmaceuticals, medical and veterinary preparations for the treatment of oncological diseases, and immune and autoimmune diseases and immunologic def Read More

Classification Information

Class [005]
Pharmaceuticals, medical and veterinary preparations for the treatment of oncological diseases, and immune and autoimmune diseases and immunologic deficiency syndromes; anticancer preparations; antitumor drugs; vaccines for human and veterinary use; anticancer vaccines for human and veterinary use; synthetic peptides, recombinant proteins, antibodies, antibody derivatives, antibody-drug conjugates, nucleotides and nucleotide analogs all for the treatment of oncological diseases, and immune and autoimmune diseases for medical and veterinary purposes; biological preparations for the treatment of oncological diseases, and immune and autoimmune diseases for medical and veterinary purposes; cellular preparations for the treatment of oncological, and immune and autoimmune diseases for medical and veterinary purposes; anti-infectives; biological tissue from blood or bone marrow intended for subsequent implantation; radiopharmaceutical preparations for diagnostic, medical and veterinary use; pharmaceutical preparations for the treatment of autoimmune diseases and diabetes; clinical diagnostic reagents; diagnostic agents, preparations and diagnostic kits comprised of medical diagnostic reagents for testing of bodily fluids and tissues for use in testing and detection of oncological, infectious, immune or autoimmune diseases for medical and veterinary purposes; drug delivery agents in the form of dissolvable tablets, capsules, gels, micelles, liposomes, particles, nanoparticles, ointment and creams, that facilitate the delivery of pharmaceutical preparations; adjuvants for use with vaccines; dietetic substances consisting of vitamins, minerals, amino acids, trace elements, starch, and dietetic sugar substitutes and diabetic bread for medical use

Classification kind code

11

Class [042]
Scientific services, namely, research and development in the field of antineoplastic and immunomudulating agents relating thereto; industrial analysis and research services in the field of pharmaceuticals and biotechnology; scientific research for medical and veterinary purposes; scientific research and development for medical and veterinary purposes in the area of cancerous diseases, autoimmune diseases or diabetes; drug development services; conducting clinical trials for others; preclinical and clinical research in the field of oncological, infectious, immune and autoimmune diseases; analysis of toxicology and mode of action of biologicals, chemicals and combinations on animals; pharmaceutical and biological product research, development, safety, efficacy and quality control testing services; scientific research and development for diagnostic purposes in the field of oncological, infectious, immune and autoimmune diseases; computer-aided diagnostic testing services; design and development of computer software and databases; design and development of computer software and databases for logistics, supply chain management and laboratory management in the fields of oncology and autoimmune disease and cancer and autoimmune research

Classification kind code

11

Class [044]
Medical services in the field of oncological, infectious, immune and autoimmune diseases; medical diagnostic services

Classification kind code

11

Mark Details

Serial Number

1851998

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 42
on 10th Jun 2020		Advertised
Submitted for opposition 26
on 26th May 2020		Approved
Submitted for opposition 27
on 26th May 2020		Approval Notice Sent
Submitted for opposition 15
on 23rd Dec 2019		Correspondence Created
Submitted for opposition 15
on 23rd Apr 2019		Correspondence Created
Submitted for opposition 22
on 30th Aug 2018		Search Recorded
Submitted for opposition 20
on 30th Aug 2018		Examiner's First Report
Submitted for opposition 31
on 15th Aug 2017		Formalized
Submitted for opposition 1
on 11th Aug 2017		Created
Submitted for opposition 30
on 10th Aug 2017		Filed